Abstract: In an internal combustion engine having a cylinder in which an air-fuel mixture of gaseous fuel and intake air is combusted, an intake passage connected to the cylinder, and a supercharger for supercharging the intake air, in a case where backfire is generated in a set period before supercharging is performed by the supercharger, supercharging is performed at a smaller supercharging pressure than in a case where backfire is not generated in the set period.

Abstract: In an internal combustion engine having a cylinder in which an air-fuel mixture of gaseous fuel and intake air is combusted, an intake passage connected to the cylinder, and a supercharger for supercharging the intake air, in a case where backfire is generated in a set period before supercharging is performed by the supercharger, supercharging is performed at a smaller supercharging pressure than in a case where backfire is not generated in the set period.

Abstract: Problem: The invention provides a polyimide precursor as well as a resin composition thereof that is excellent in coating properties of slit coating as well as productivity and also excellent in optical properties that are required for applications of flexible substrates. Solution: The polyimide precursor comprises a structure unit derived from a fluorene backbone and a silicon-containing structure unit, and a weight-average molecular weight of the polyimide precursor is 90,000 to 250,000.

Abstract: Disclosed is a composition comprising a silicon-containing compound represented by the general formula (1) mentioned in the description of the present application, at least one compound of the general formula (2-1) or (2-2) in which m is an integer of 3 or greater mentioned in the description of the present application, and optionally a compound represented by the general formula (3). The total amount of the silicon-containing compound of the general formula (2-1) or (2-2) in which m is an integer of 3 or greater is more than 0 ppm and 46,000 ppm or less based on the total weight of the silicon-containing compounds of the general formulas (1), (2-1), (2-2), and (3). The composition is used for producing a polyimide precursor obtained by copolymerizing a silicon-containing compound, tetracarboxylic dianhydride, and diamine.

Abstract: Problem: The invention provides a polyimide precursor as well as a resin composition thereof that is excellent in coating properties of slit coating as well as productivity and also excellent in optical properties that are required for applications of flexible substrates. Solution: The polyimide precursor comprises a structure unit derived from a fluorene backbone and a silicon-containing structure unit, and a weight-average molecular weight of the polyimide precursor is 90,000 to 250,000.

Abstract: A solvent for a resin composition that includes a polyimide precursor having a structure unit derived from polyamic acid and a structure unit derived from siloxane having a monovalent aliphatic hydrocarbon group of 1 to 5 carbon atoms or a monovalent aromatic group of 6 to 10 carbon atoms. The solvent is a mixture of an amide-based solvent and a non-amide-based solvent having a boiling point of 160° C. or higher, and the resin composition includes cyclic siloxane.

Abstract: Provided is a resin composition including a polyimide precursor that has exceptional adhesiveness to glass substrates and that does not generate particles during laser detachment. A resin composition containing (a) a polyimide precursor, (b) an organic solvent, and (d) an alkoxysilane compound, wherein the resin composition shows polyimide obtained by imidation of the (a) polyimide precursor after application of the resin composition to the surface of a support, the residual stress with the support is from ?5 MPa to 10 MPa, and the 308 nm absorbance of the (d) alkoxysilane compound when made into a 0.001 mass % NMP solution is from 0.1 to 0.5 at a solution thickness of 1 cm.

Abstract: Not only acute or chronic interstitial pneumonia and plumonary fibrosis but also chronic obstructive plumonary diseases, such as plumonary emphysema and chronic bronchitis, can be effectively prevented or treated by inhalation administration to the lung tissue of 2-{N-[4-(4-chlorobenzenesulfonylamino)butyl]-N-{3-[(4-isopropyl 2-thiazolyl)methoxy]benzyl}}-sulfamoylbenzoic acid or a pharmacologically acceptable salt thereof.

Abstract: The present invention relates to a preparation, particularly a topical preparation, for the therapy of wounds or hemorrhoids, which contains, as an active ingredient, at least one of prostaglandin I.sub.2, prostaglandin E.sub.1 and derivatives of these, particularly beraprost, a derivative of prostaglandin I.sub.2, or a salt thereof, and a method of the therapy of wounds or hemorrhoids, which comprises administering the above active ingredient.

Abstract: The present invention relates to a preparation, particularly a topical preparation, for the therapy of wounds or hemorrhoids, which contains, as an active ingredient, at least one of prostaglandin I.sub.2, prostaglandin E.sub.1 and derivatives of these, particularly beraprost, a derivative of prostaglandin I.sub.2, or a salt thereof, and a method of the therapy of wounds or hemorrhoids, which comprises administering the above active ingredient.

Abstract: The present invention relates to a preparation, particularly a topical preparation, for the therapy of wounds or hemorrhoids, which contains, as an active ingredient, at least one of prostaglandin I.sub.2, prostaglandin E.sub.1 and derivatives of these, particularly beraprost, a derivative of prostaglandin I.sub.2, or a salt thereof, and a method of the therapy of wounds or hemorrhoids, which comprises administering the above active ingredient.

Abstract: A chromene derivative having the general formula (I): ##STR1## wherein n is 1 to 5 and --O--CH.sub.2).sub.n CO.sub.2 H group is attached to 5-position, 6-position, 7-position or 8-position, or salts thereof, a process for preparing the same and antiallergic agents containing the same.The compounds of the present invention inhibit the immunological release of chemical mediators such as SRS-A and histamine from mast cell and have an excellent effect in preventing and treating the various allergic diseases such as allergic asthma, allergic dermatitis, allergic nasitis, hives, allergic enteritis and allergic conjunctivitis, especially allergic asthma.